Cancer Biomarkers Market Size $50.47 Billion by 2030
Report Overview:
The Global Cancer Biomarkers Market achieved a valuation of $14.08 Billion in 2022 and is anticipated to exceed $50.47 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 17.3% during the forecast period from 2024 to 2032.
Key Market Players:
F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (US), Qiagen N.V. (Netherlands),...
0 Comments
0 Shares